3-[1-hydroxy-2-[(4-phenylphenyl)methylamino]ethyl]phenol;Benzenemethanol, α-[[([1,1'-biphenyl]-4-ylmethyl)amino]methyl]-3-hydroxy-;AC 73,AC73;AC-73 | Autophagy;3-{2-[([1,1'-biphenyl]-4-ylmethyl)amino]-1-hydroxyethyl}phenol;AC-73, 10 mM in DMSO
AC-73 is the first orally bioavailable, specific inhibitor of Cluster of Differentiation 147 (CD147), which selectively disrupts CD147 dimerization by targeting the N-terminal IgC2 domain (involving Glu64 and Glu73), thereby inhibiting the CD147/ERK1/2/STAT3/MMP-2 signaling pathway and suppressing migration and invasion of hepatocellular carcinoma cells; it also acts as an antiproliferative agent and an inducer of autophagy in leukemia cells.